research peptides FAQ

Verify chemical compatibility before mixing. Some peptides undergo cross-reaction, pH-mediated degradation, or competitive binding that reduces effective concentration. Incretin agonists like tirzepatide and survodutide should not be co-administered in the same injection due to receptor competition and unpredictable pharmacokinetics. Neuroprotective peptides like Cerebrolysin and Dihexa can be administered in separate sites simultaneously because they act on distinct receptor systems (NGF/BDNF mimicry versus HGF/c-Met activation). Senolytic peptides like FOXO4-DRI and mitochondrial-targeting compounds like SS-31 address non-overlapping mechanisms and can be combined, but timing matters. Senolytics induce apoptosis while SS-31 enhances mitochondrial function, so sequential rather than simultaneous administration may optimize outcomes. Consult published combination studies when available, or conduct preliminary stability and activity assays before committing to a full experimental protocol.

Gently swirl the vial. Never shake it. Vigorous shaking introduces air bubbles and mechanical shear forces that can denature peptides by disrupting their secondary structure. If gentle swirling doesn't achieve full dissolution within 2–3 minutes, allow the vial to sit at room temperature for 5–10 minutes and swirl again. Some lyophilized peptides form a loose cake that requires time to hydrate fully. If the peptide still hasn't dissolved after 15 minutes, the issue is likely incorrect solvent choice, incorrect solvent volume, or a manufacturing defect. Do not apply heat, use a vortex mixer, or add additional solvent beyond the specified reconstitution volume. Contact the supplier instead.

Use bacteriostatic water unless the peptide-specific protocol specifies otherwise. Bacteriostatic water. Sterile water containing 0.9% benzyl alcohol as a preservative. Is the default reconstitution solvent for most research peptides because it prevents bacterial growth in multi-dose vials while maintaining neutral pH. Some peptides require acetic acid solution (0.1–1% acetic acid in sterile water) if the sequence is prone to aggregation at neutral pH. This is common for highly hydrophobic peptides. A few peptides, such as certain GLP-1 receptor agonists, may specify reconstitution with saline (0.9% sodium chloride). The Certificate of Analysis or product specification sheet should state the recommended solvent. If no guidance is provided, bacteriostatic water is the safest default, but contact the supplier for confirmation before proceeding.

Lyophilised peptides tolerate brief temperature excursions better than reconstituted solutions, but 'brief' means hours, not days. Unreconstituted peptides exposed to ambient temperature (20–25°C) for 24–48 hours typically retain 85–95% activity, but exposure above 30°C or longer durations cause progressive denaturation that cannot be reversed. If a package arrives warm or a freezer failure occurs, measure or estimate the exposure duration and temperature. For lyophilised peptides exposed to room temperature for <48 hours, reconstitute a small test aliquot and verify appearance and pH before committing the full batch. If appearance is normal, biological activity may be preserved but should be confirmed with a pilot dose-response experiment. For reconstituted peptides exposed to >8°C for any duration, discard the solution. Once the cold chain breaks, protein stability cannot be recovered.

Discard it immediately. Cloudiness indicates aggregation, contamination, or precipitation, all of which signal that the peptide is no longer in solution as individual molecules. Properly reconstituted peptides should appear as clear, colorless solutions. Visible particles suggest either incomplete dissolution (solvable by gentle swirling, never shaking) or protein aggregation caused by improper pH, ionic strength, or temperature. Aggregated peptides lose biological activity and can introduce immunogenic responses in biological assays. Never filter or centrifuge a cloudy peptide solution and attempt to use the supernatant. The aggregation process has already compromised molecular structure.

Do not use it. Contact the supplier immediately. Lyophilized peptides tolerate short-term temperature fluctuations better than reconstituted solutions, but any shipment that arrives above 25°C for extended periods (>48 hours) carries denaturation risk. Peptide bonds are stable in dry form, but the three-dimensional structure required for receptor binding can be disrupted by heat exposure even before reconstitution. If the vial feels warm to the touch on arrival, the peptide may have undergone partial denaturation. And there is no reliable home test to verify structural integrity. Reputable suppliers include temperature data loggers in shipments or offer guaranteed cold-chain handling with reshipment policies if thermal exposure is documented.

Do not use it. Visible cloudiness, particulate matter, or discoloration indicates protein denaturation, aggregation, or contamination. Reconstituted peptides should appear clear and colorless (or match the expected appearance documented in the product specification sheet). Protein aggregation occurs when tertiary structure breaks down due to temperature excursions, pH incompatibility, or mechanical agitation during mixing. Aggregated peptides lose biological activity and can produce spurious experimental results. Attempting to filter or centrifuge the solution will not restore activity. Document the appearance with photographs, store the vial at 2–8°C, and contact the supplier immediately with batch number and visual documentation for replacement and root cause analysis.

Inspect the temperature indicator card immediately before opening the vial. If the indicator shows cumulative time above 8°C exceeded the safe threshold (typically marked with a red or black indicator line), contact the supplier for replacement before reconstituting. Using a degraded peptide wastes both the compound and your Bacteriostatic Water, and introduces false negatives into your research data. Most reputable suppliers, including Real Peptides, replace shipments with confirmed temperature excursions at no charge, which is why temperature verification matters more than anecdotal "it felt cold enough."

Move reconstituted thymalin to a more stable refrigeration unit immediately and monitor temperature with a dedicated thermometer. Most household refrigerators cycle between 2–10°C depending on door-opening frequency and cooling system quality. If your unit regularly exceeds 8°C, use a pharmaceutical-grade mini-fridge with digital temperature monitoring or store peptides in the coldest section (typically the back corner of the middle shelf, away from the door). Temperature logs are standard practice in research labs for this exact reason. A $25 wireless thermometer with app alerts prevents peptide loss from unnoticed temperature drift.

Specify "signature required" delivery and confirm someone will be present to receive the package and immediately refrigerate it. Peptide shipments left on doorsteps in ambient temperatures for 4–6 hours during summer months experience the same thermal stress as multi-day transit delays. If you're ordering temperature-sensitive compounds like Tirzepatide or Retatrutide for delivery while you're away, arrange for the package to be held at the carrier facility for pickup. FedEx and UPS both offer refrigerated hold services at major hubs, which maintains cold-chain integrity better than residential delivery during your absence.

International Adamax shipping faces the highest degradation risk during customs holds, where packages sit in unrefrigerated warehouses for 3–10 days regardless of PCM pack capacity. If tracking shows your peptide shipment has been in customs for more than 72 hours, assume cold-chain breach and request replacement upon delivery. The phase-change materials are exhausted, and the peptides have likely experienced temperature excursions. This is why Real Peptides recommends domestic sourcing for researchers based in regions where we maintain licensed distribution, avoiding the customs variable entirely.

If more than 28 days may have passed, discard the vial and reconstitute fresh thymalin. The risk of bacterial contamination and peptide degradation beyond this window outweighs the cost of replacement. Bacteriostatic water's antimicrobial efficacy declines sharply after four weeks, and even if contamination hasn't occurred, chemical and enzymatic degradation reduce potency unpredictably. Researchers working with time-sensitive studies cannot afford the data variability introduced by degraded peptides. Consistent potency is foundational to reproducible results.

Discard the vial. Freezing reconstituted peptides causes ice crystal formation that irreversibly denatures the protein structure through aggregation and precipitation. Even if the solution appears clear after thawing, HPLC analysis consistently shows 40–70% potency loss and altered molecular weight distribution indicating peptide fragmentation. This is not salvageable. Attempting to use freeze-damaged peptides produces inconsistent research outcomes that compromise data integrity. The correct response is to reconstitute a fresh vial and adjust refrigerator settings to prevent future freezing.

PCM packs are designed to thaw during transit. That's the mechanism by which they absorb heat and maintain stable internal temperature. A fully thawed pack after 24–48 hours transit is expected and indicates the system worked correctly. The concern is when packs are still frozen solid (indicating the peptide may have been stored below −20°C, which can cause vial cracking) or when they're not just thawed but warm (indicating the thermal buffer was exhausted hours before delivery). Check the temperature indicator card. That's the definitive verification, not the physical state of the PCM packs.

This is a missed opportunity for outcome measurement. Kisspeptin's efficacy is tied directly to its ability to elevate LH, which then stimulates gonadal testosterone or estradiol production. Without baseline and post-administration hormone panels, researchers can't confirm receptor engagement or dose-response relationships. A 2018 paper in The Journal of Clinical Investigation demonstrated that kisspeptin-10 doses as low as 0.24 nmol/kg elevated LH by 2–3-fold within 60 minutes. But the magnitude of response varied with baseline gonadotropin suppression. Measuring LH and sex steroids is the only way to verify mechanism.

This indicates structural degradation, incorrect sequencing, or contamination. Kisspeptin analogs that lack the C-terminal amidated phenylalanine residue lose nearly all GPR54 binding affinity. If a batch produces no measurable LH elevation at doses that should trigger a 2–4-fold increase, the peptide is likely inactive. This is why third-party verification through HPLC and mass spectrometry is non-negotiable. Visual inspection or even basic purity testing doesn't catch sequence errors. We've identified peptide batches from offshore suppliers that contained only 60–70% of the labeled compound, with the remainder being acetylated fragments or synthesis byproducts.

This is mechanistically valid because the pathways don't overlap. Kisspeptin stimulates the HPG axis while GHRP-2 or MK-677 activates the GH/IGF-1 axis. Both can operate simultaneously without receptor competition. A 2020 study in Frontiers in Endocrinology combined kisspeptin-10 with ipamorelin in hypogonadal rodent models and found additive effects on lean mass and bone density, with no adverse interaction. However, study design must account for pulsatility differences. Kisspeptin requires bolus dosing to mimic natural GnRH pulses, while continuous GH elevation from daily MK-677 dosing operates on a different timescale.

Store lyophilized peptides in separate labeled containers to prevent mix-ups, and keep reconstituted peptides in a dedicated refrigerator section away from biological samples that could contaminate them. Cross-contamination during storage is less common than during synthesis, but labeling errors account for approximately 15% of reported peptide mix-ups in multi-compound research labs. Use color-coded labels or barcode systems for high-throughput facilities.

Incomplete solubility indicates aggregation, often caused by temperature excursion during shipping or oxidation during storage. Aggregated peptides can't be rescued. Heating, sonication, or pH adjustment won't restore monomeric structure. Discard the vial and request a replacement. If the supplier blames your reconstitution technique, that's a deflection. Properly stored peptides dissolve completely in the specified solvent at the stated concentration.

Cloudiness in a reconstituted peptide solution indicates aggregation or precipitation. The peptide is no longer in a homogeneous solution state and concentration measurements are unreliable. Do not attempt to use cloudy solutions. Aggregation can result from incorrect reconstitution solvent (using pure water instead of bacteriostatic water), storage at room temperature, or freeze-thaw cycles. Discard the solution and reconstitute a fresh vial using the correct protocol.